Proneuron Biotechnologies, Inc. (US Branch)'s Phase II Experimental ProCord Procedure For Complete Spinal Cord Injury Now Available At The Mount Sinai Medical Center In NY & University Hospital In Collaboration With Kessler Institute For Rehabilitation In NJ
10/19/2005 5:12:23 PM
Proneuron Biotechnologies (www.proneuron.com) announced today that The Mount Sinai Medical Center and University Hospital in collaboration with Kessler Institute for Rehabilitation are now enrolling patients as treatment sites in the Phase II study of ProCord for complete spinal cord injury. University Hospital patients will receive post-procedure rehabilitation at Kessler Institute for Rehabilitation in West Orange, NJ. Patients enrolled at the New York site will receive all procedures at The Mount Sinai Medical Center. Progenitor Cell Therapy, LLC (PCT, Hackensack, NJ) will provide the required cell processing facility for the manufacturing of ProCord for both sites. The Mount Sinai Medical Center and Kessler Institute for Rehabilitation became referral sites in June 2004.